Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: Agilent Technologies ×

Agilent Technologies

This institution is selected. Its supporting articles are shown below.

Agilent Technologies1

Articles mentioning Agilent Technologies

1 articles · page 1 of 1

CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer

bmjonc · full text · 2026-03-31 · 1 matching annotations

80.1%

Caris Life Sciences Agilent Technologies pembrolizumab pembrolizumab-treated CRC pancreatic cancer

…ofiling (WES, whole-transcriptome sequencing, IHC) performed at Caris Life Sciences. Based on RNA sequencing data, samples were analysed to quantif…

Browse institutions

Agilent Technologies

Articles mentioning Agilent Technologies

CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer